| Title | Effect of early versus deferred antiretroviral therapy for HIV on survival. |
| Publication Type | Journal Article |
| Year of Publication | 2009 |
| Authors | Kitahata, Mari M., Stephen J. Gange, Alison G. Abraham, Barry Merriman, Michael S. Saag, Amy C. Justice, Robert S. Hogg, Steven G. Deeks, Joseph J. Eron, John T. Brooks, Sean B. Rourke, John M. Gill, Ronald J. Bosch, Jeffrey N. Martin, Marina B. Klein, Lisa P. Jacobson, Benigno Rodriguez, Timothy R. Sterling, Gregory D. Kirk, Sonia Napravnik, Anita R. Rachlis, Liviana M. Calzavara, Michael A. Horberg, Michael J. Silverberg, Kelly A. Gebo, James J. Goedert, Constance A. Benson, Ann C. Collier, Stephen E. Van Rompaey, Heidi M. Crane, Rosemary G. McKaig, Bryan Lau, Aimee M. Freeman, and Richard D. Moore |
| Corporate Authors | NA-ACCORD Investigators |
| Journal | The New England journal of medicine |
| Volume | 360 |
| Issue | 18 |
| Pagination | 1815-26 |
| Date Published | 2009 Apr 30 |
| ISSN | 1533-4406 |
| Keywords | Adult, Anti-Retroviral Agents, CD4 Lymphocyte Count, Confounding Factors (Epidemiology), Drug Administration Schedule, Female, HIV, HIV Infections, Humans, Male, Middle Aged, Proportional Hazards Models, Risk, RNA, Viral, Survival Analysis |
| Abstract | The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain. |
| DOI | 10.1056/NEJMoa0807252 |
| Alternate Journal | N. Engl. J. Med. |
